Records containing: Major Depressive Disorder

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2012-04-30
  Feasibility and Efficacy of a Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
• CLINICAL_TRIALS study record update · 2012-04-19
  A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-04-19
  Using the Internet to Provide Disease Management and Improve Compliance Among Bipolar and Depressed Patients
• CLINICAL_TRIALS study record update · 2012-04-19
  Pharmacogenetic Study of CYP450 2D6 and 2C19 in Patients With Significant Adverse Effects From Antidepressants
• CLINICAL_TRIALS study record update · 2012-04-19
  Tai Chi Training for Treating Depressed Chinese Americans
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-04-13
  The Efficacy of Parent Involvement in the Treatment of Adolescent Depression
• CLINICAL_TRIALS study record update · 2012-04-10
  A Phase II, Multi-center, Randomized, Double-bind, Double-dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of AZD7268 in Patients With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-04-06
  Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults With Clinically Significant, Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-04-03
  A Double-blind Placebo Controlled Trial of Pregnenolone for Depression in Patients With Bipolar Disorders or Recurrent Major Depressive Disorder and a History of Substance Abuse
• CLINICAL_TRIALS study record update · 2012-03-30
  A Multicenter, Parallel-Group, Randomized, 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of 50 mg Of DVS SR In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-03-27
  An Open-label, Follow-up Study on Remitted Patients With Major Depressive Disorder Using Transcranial Direct Current Stimulation
• CLINICAL_TRIALS study record update · 2012-03-23
  A Non - Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient Diagnosed as With Treatment Resistant Major Depressive Disorder (MDD)
• CLINICAL_TRIALS study record update · 2012-03-07
  Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD), a Prospective, Randomized, Multi-center Study to Determine the Efficacy of Selected EEG and Genotype Biomarkers for Predicting Response to Antidepressant Therapy With Escitalopram, Bupropion XL, or a Combination Treatment Regimen.
• CLINICAL_TRIALS study record update · 2012-03-06
  A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-03-05
  Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-03-05
  Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-02-22
  A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered With Venlafaxine in Subjects With Major Depressive Disorder (MDD) and Co-existing Insomnia
• CLINICAL_TRIALS study record update · 2012-02-17
  A Randomized, Double-Blind, Parallel Group Study To Compare Discontinuation Symptoms In Abrupt Discontinuation Versus A 1-Week Tapering Regimen In Subjects With MDD Treated For 24 Weeks With Open-Label 50 mg DVS SR Formulation
• CLINICAL_TRIALS study record update · 2012-02-15
  An International, Open-Label Extension Study of the Safety and Tolerability of CORLUX™ (Mifepristone) for Recurrent Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
• CLINICAL_TRIALS study record update · 2012-02-15
  An International, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of CORLUX™ (Mifepristone) vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Psychotic Major Depression (PMD)
• CLINICAL_TRIALS study record update · 2012-02-15
  A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Three Dose Levels of CORLUX™ (Mifepristone) Plus an Antidepressant vs. Placebo Plus an Antidepressant in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features (PMD)
• CLINICAL_TRIALS study record update · 2012-02-15
  A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of CORLUX™ (Mifepristone) in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
• CLINICAL_TRIALS study record update · 2012-02-13
  Duloxetine Versus Placebo in the Acute Treatment of Patients With Major Depressive Disorder and Associated Painful Physical Symptoms
• CLINICAL_TRIALS study record update · 2012-02-10
  A Double-blind Sham Controlled Trial of Transcranial Direct Current Stimulation (tDCS) in Treating Refractory Major Depressive Disorder (MDD)
• CLINICAL_TRIALS study record update · 2012-02-08
  Desvenlafaxine Succinate in Major Depressive Disorder: Effects on Structural and Functional Imaging, Cognition, and Functional Outcomes in Midlife Women and Men